ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1533

Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses

Anne-Lise Gaillard1, Thomas Barnetche2 and Thierry Schaeverbeke3, 1Rhumatologie, CHU Bordeaux Pellegrin, Bordeaux, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology Department, Bordeaux Hospital, Bordeaux, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fertility, outcomes, pregnancy, rheumatoid arthritis (RA) and women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Actually better control of rheumatoid arthritis (RA) activity leads to new interrogations and daily questions about pregnancy. Only few studies have studied pregnancy outcomes in women with RA, and results have shown some discrepancies. The objective is to determine the effect of Rheumatoid Arthritis on pregnancy outcomes, specially hypertension and preeclampsia, low birth weight, preterm birth, perinatal mortality, congenital malformation and cesarean section in women with Rheumatoid Arthritis

Methods: A litterature search was performed from Medline and Cochrane databases for articles published in english from 1955 to May 2016. Studies were eligible if they presented prevalence study, including national birth registry. Population were women with Rheumatoid Arthritis and keys terms related to pregnancy outcomes. Meta-analysis were performed to assess odds-ratios (OR) for each studied group using the inverse variance approach to estimate pooled OR with their 95% confidence interval (95% IC). Heterogeneity was assessed according to Cochran’s Q-test and I2 values. Calculations were made with the Cochrane RevMan 5.3 software. P-values less than 0.05 were considered as significant.

Results: Expanded literature searche identified 1002 papers, of which 68 were eligible. Meta-analysis calculations showed a significant increased risk of prematurity with an OR of 1,42 (95% CI 1,29 to 1,56), low birth weight with an OR of 1,53(95% CI 1,35 to 1,75), small size at birth with an OR of 1,22 (95% IC : 1,00 to 1,48), perinatal mortality with an OR of 1,84(95% IC 1,25 to 2,72), preeclampsia with an ORof 1,46 (95% IC 1,06 to 1,85) , cesarean with an OR of 1,52 (95%IC 1,25 to 1,85). We did not find a higher risk of congenital malformation , hypertension or instrumental delivery. A higher risk of pregnancy outcomes seems to be showed before the disease onset. Furthermore, disease activity and drug treatment such as NSAIDs and corticosteroids should decrease fertility and increase pregnancy outcomes and specially prematurity and miscarriage.

Conclusion: A significative higher risk of several pregnancy outcomes in women with Rheumatoid Arthritis . Rheumatologist should be advised of these risks to refer women in apropriate obstectrics department. 


Disclosure: A. L. Gaillard, Abbvie, 7; T. Barnetche, None; T. Schaeverbeke, Abbvie, 7.

To cite this abstract in AMA style:

Gaillard AL, Barnetche T, Schaeverbeke T. Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/pregnancy-outcomes-in-women-with-rheumatoid-arthritis-a-systematic-review-and-meta-analyses/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pregnancy-outcomes-in-women-with-rheumatoid-arthritis-a-systematic-review-and-meta-analyses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology